202 related articles for article (PubMed ID: 36902125)
1. Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.
Ortiz-Soto G; Babilonia-Díaz NS; Lacourt-Ventura MY; Rivera-Rodríguez DM; Quiñones-Rodríguez JI; Colón-Vargas M; Almodóvar-Rivera I; Ferrer-Torres LE; Suárez-Arroyo IJ; Martínez-Montemayor MM
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902125
[TBL] [Abstract][Full Text] [Related]
2. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells.
Zhao Y; Kong X; Li X; Yan S; Yuan C; Hu W; Yang Q
PLoS One; 2011; 6(12):e29363. PubMed ID: 22195048
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
4. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
[TBL] [Abstract][Full Text] [Related]
5. miR‑3664‑5P suppresses the proliferation and metastasis of gastric cancer by attenuating the NF‑κB signaling pathway through targeting MTDH.
Jiao Y; Yang H; Qian J; Gong Y; Liu H; Wu S; Cao L; Tang L
Int J Oncol; 2019 Mar; 54(3):845-858. PubMed ID: 30628643
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory breast cancer (IBC): clues for targeted therapies.
Fernandez SV; Robertson FM; Pei J; Aburto-Chumpitaz L; Mu Z; Chu K; Alpaugh RK; Huang Y; Cao Y; Ye Z; Cai KQ; Boley KM; Klein-Szanto AJ; Devarajan K; Addya S; Cristofanilli M
Breast Cancer Res Treat; 2013 Jul; 140(1):23-33. PubMed ID: 23784380
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
8. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.
Wang X; Saso H; Iwamoto T; Xia W; Gong Y; Pusztai L; Woodward WA; Reuben JM; Warner SL; Bearss DJ; Hortobagyi GN; Hung MC; Ueno NT
Cancer Res; 2013 Nov; 73(21):6516-25. PubMed ID: 24014597
[TBL] [Abstract][Full Text] [Related]
9. The multifaceted role of MTDH/AEG-1 in cancer progression.
Hu G; Wei Y; Kang Y
Clin Cancer Res; 2009 Sep; 15(18):5615-20. PubMed ID: 19723648
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
Mineva ND; Paulson KE; Naber SP; Yee AS; Sonenshein GE
PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
12. miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.
Yang L; Liu S; Yang L; Xu B; Wang M; Kong X; Song Z
Oncol Lett; 2022 May; 23(5):162. PubMed ID: 35399330
[TBL] [Abstract][Full Text] [Related]
13. The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells.
Pan D; Jia Z; Li W; Dou Z
Int J Oncol; 2019 Jun; 54(6):1955-1968. PubMed ID: 31081051
[TBL] [Abstract][Full Text] [Related]
14. Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway.
Fang J; Zhu H; Xu P; Jiang R
J Recept Signal Transduct Res; 2022 Aug; 42(4):409-417. PubMed ID: 34645355
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
Arora J; Sauer SJ; Tarpley M; Vermeulen P; Rypens C; Van Laere S; Williams KP; Devi GR; Dewhirst MW
Oncotarget; 2017 Apr; 8(16):25848-25863. PubMed ID: 28460441
[TBL] [Abstract][Full Text] [Related]
16. Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity.
Xu B; Yang L; Yang L; Al-Maamari A; Zhang J; Song H; Wang M; Su S; Song Z
Cancer Biol Ther; 2024 Dec; 25(1):2321767. PubMed ID: 38417050
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
Liu Y; Wei G; Ma Q; Han Y
Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
[TBL] [Abstract][Full Text] [Related]
18. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
[TBL] [Abstract][Full Text] [Related]
19. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
20. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q
J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
